Hints and tips:
Related Special Reports
...IP is not the limiting factor at this stage, says David Loew, executive vice-president at Sanofi Pasteur. “Most vaccines don’t even have IP....
...Analyst David Buxton at FinnCap, said the growing order book was a good sign for the second half....
International Edition